Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • COVID-19
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • Topics A-Z
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • COVID-19
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • Topics A-Z
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

Share

March 13, 2012; 78 (11) Resident and Fellow Section

Clinical Reasoning: A 13-year-old boy presenting with dystonia, myoclonus, and anxiety

Joanna S. Blackburn, Melissa L. Cirillo
First published March 12, 2012, DOI: https://doi.org/10.1212/WNL.0b013e318249f6cc
Joanna S. Blackburn
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Melissa L. Cirillo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Clinical Reasoning: A 13-year-old boy presenting with dystonia, myoclonus, and anxiety
Joanna S. Blackburn, Melissa L. Cirillo
Neurology Mar 2012, 78 (11) e72-e76; DOI: 10.1212/WNL.0b013e318249f6cc

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
1053

Share

  • Article
  • Info & Disclosures
Loading

SECTION 1

A 13-year-old, right-handed boy was referred for movement and speech abnormalities. His mother reports his voice becoming soft and choppy at 8 years of age. Over the past year, he developed head jerking to the right while using his right hand. The patient denied a premonitory urge or ability to suppress these movements. They had become so disabling that he had to eat and write with his left hand. He has no other medical problems, other than a pectus excavatum. His family history is notable for his father being diagnosed with Tourette syndrome as a teen. His father continues to have episodic head jerking to the left at times. The patient's general examination was notable for an anxious teenager with marfanoid features including pectus excavatum and long limbs. The patient's neurologic examination revealed strained, choppy speech, which was present while speaking but not while singing. He had involuntary forced head turn to the right with right tilt and right upper extremity sustained twisting posturing when trying to use his right hand. He had right upper extremity fast jerking movements with attempts to use his right arm. His deep tendon reflexes were brisk, with crossed adductors. The remainder of his neurologic examination was normal.

Question for consideration:

  1. What type of movement is being described in the history?

GO TO SECTION 2

SECTION 2

Although his father had been diagnosed with Tourette syndrome, the patient's movements were neither suppressible nor preceded by an urge, which are the hallmarks of tics. The strained choppy voice was consistent with spasmodic dysphonia, a form of laryngeal dystonia. His forced head turn to the right and twisting posturing was consistent with cervical dystonia and limb dystonia, respectively. The jerking movements of his arm suggested a dystonic tremor vs myoclonus. On his initial examination it was difficult to differentiate between these 2 involuntary movements.

Questions for consideration:

  1. What is the definition of dystonia?

  2. What is the differential diagnosis for dystonia with onset in childhood or early adolescence?

  3. What diagnostic tests would you order?

GO TO SECTION 3

SECTION 3

Dystonia in childhood has been defined as a movement disorder with involuntary sustained or intermittent muscle contractions which cause twisting and repetitive movements, abnormal postures, or both.1

A broad differential diagnosis must be considered in the evaluation of childhood or adolescent onset dystonia, including primary dystonias, dystonia plus syndromes, secondary dystonias, and heredodegenerative disorders.2,3 Primary dystonias do not have other neurologic or systemic findings. The most common primary dystonia is DYT-1 dystonia, which is typically characterized by childhood onset limb dystonia often with subsequent generalization.2,3 It is an autosomal dominant disease with a penetrance rate of 30%–40% which is caused by a GAG deletion in the TOR1A gene. Dystonia plus syndromes include additional neurologic findings such as parkinsonism and myoclonus.4 Two dystonia plus syndromes are dopa-responsive dystonia (DYT 5) and myoclonus dystonia (DYT 11). Dopa-responsive dystonia (DYT 5) typically presents in midchildhood with gait dystonia. There is diurnal variation in symptoms in 75% of patients.2 Other possible associated features include parkinsonism and hyperreflexia.2,3 A key feature of this condition is a dramatic and sustained response to levodopa.2,3 It is caused by a mutation in the GTP-cyclohydrolase-I gene. The presence of myoclonus in association with dystonia is characteristic of myoclonus dystonia (DYT 11).2,3 Secondary and heredodegenerative dystonias typically present with other neurologic and systemic signs and symptoms in addition to dystonia. Secondary dystonia is due to an acquired or exogenous cause including drug exposures, toxins, infections, and focal CNS lesions.3 Important historical information includes drug or toxin exposure, perinatal injury, encephalitis, or head trauma. A focal structural lesion may present with hemidystonia. Heredodegenerative disorders which have dystonia as a feature are genetic disorders including Huntington disease, Wilson disease, and pantothenate kinase–associated neurodegeneration.2 These are often associated with other signs including cognitive impairment, seizures, oculomotor dysfunction, retinal abnormalities, neuropathy, spasticity, as well as liver dysfunction and skeletal abnormalities.

Our patient presented with dystonia, a dystonic tremor vs myoclonus, and marfanoid features. In addition, on further examination of the patient's father, his findings were more consistent with myoclonus rather than tics. His father also reported that his head jerking resolved with alcohol use. This suggests the most likely diagnosis was either a primary dystonia or a dystonia plus syndrome. The patient's abnormal movements were unilateral, so a focal etiology was considered. Given the presence of marfanoid features, abnormal vessels leading to a basal ganglia stroke was considered. Marfanoid features are not associated with a primary dystonia or dystonia plus syndrome. The following laboratory testing was normal: complete blood count, complete metabolic panel, copper, ceruloplasmin, zinc, thyroid function testing, and ferritin. He had MRI of the brain and magnetic resonance angiography (MRA) of the head and neck, which showed no evidence of stroke or abnormal vessels to suggest his presentation was related to his marfanoid habitus. He had a normal ophthalmologic examination with no evidence of Kayser-Fleischer rings or retinal detachment. DYT-1 genetic testing was pending.

Question for consideration:

  1. Would you treat the patient while awaiting genetic testing results? If so, with what?

GO TO SECTION 4

SECTION 4

It is recommended that patients with early onset dystonia without an alternative diagnosis undergo a levodopa trial.4 Although our patient's presentation was not typical for dopa-responsive dystonia, he was treated with levodopa while additional genetic testing was pending. There was no clinical response to levodopa, making that an unlikely diagnosis. DYT-1 testing was negative. On repeat examination, his abnormal movements appeared to be consistent with myoclonus in addition to a dystonic tremor.

Question for consideration:

  1. What additional diagnostic testing would you send at this time?

GO TO SECTION 5

SECTION 5

Given the constellation of dystonia, myoclonus, anxiety, and his father's history, the patient was evaluated for myoclonus dystonia. Epsilon sarcoglycan gene (SGCE) testing revealed a known mutation and a diagnosis of myoclonus dystonia syndrome was made. Our patient was treated with trihexyphenidyl, which resulted in significant improvement of his myoclonus and dystonia. He was able to eat and write with his right hand and was remarkably less anxious.

DISCUSSION

Myoclonus dystonia is a rare disorder characterized by myoclonic jerks and dystonia. Presentation is typically in childhood or early adolescence.5 The most common presenting symptom is myoclonus, but dystonia can be the initial presentation in 20%.5 Myoclonus typically involves the arm and axial musculature and is responsive to alcohol. Dystonia is usually mild and most often manifests as cervical dystonia or writer's cramp. Psychiatric features are common and include depression, obsessive-compulsive behavior, panic attacks, and attention deficit hyperactivity disorder.2,5 Severity of symptoms varies. Spontaneous resolution of limb dystonia and improvement of myoclonus occur in 20% and 5%, respectively.5 Although spontaneous resolution can occur, myoclonus and dystonia can progress at any time during the disease course.5

Inheritance is autosomal dominant with reduced maternal inheritance due to maternal imprinting. Paternal inheritance always results in the disease whereas maternal inheritance has a penetrance of 10%–15%.2 Mutations in the SGCE gene, which encodes the protein epsilon sarcoglycan, is located in chromosome region 7q21. Mutations in the SGCE gene are found is less than 40% of patients with the clinical phenotype.5 There are reports of both sporadic cases as well as kindreds with SGCE-negative myoclonus dystonia. One notes a kindred presenting with autosomal dominant clinical features of myoclonus dystonia syndrome who was found to have GTP cyclohydrolase I deficiency, which is typically associated with dopa-responsive dystonia.6 The pathophysiology of myoclonus dystonia is unknown.

Treatment of myoclonus dystonia is symptomatic. Anticholinergic drugs and benzodiazepines may improve dystonia and myoclonus.5 Antiepileptic drugs including levetiracetam, piracetam, valproic acid, and zonisamide have improved myoclonus in some patients.5 Levodopa has been shown in isolated cases to improve symptoms.7 Botulinum toxin is an option to treat focal dystonia. Deep brain stimulation (DBS) of the globus pallidus interna (GPi) and ventral intermediate thalamic nucleus have been shown to improve symptoms in more than 70% of patients with DBS-GPi, having fewer adverse effects.8,9

Diagnostic criteria for definite myoclonus dystonia have been proposed and include early onset (<20 years), myoclonus predominating in the upper body either isolated or associated with dystonia, positive family history with paternal transmission when due to SGCE mutation or deletion, exclusion of additional neurologic findings such as cerebellar ataxia, spasticity, and dementia, and a normal brain MRI.5,10

Myoclonus dystonia is a rare cause of dystonia in childhood but must be considered in the setting of early onset dystonia when myoclonus is present, especially in cases with potential paternal inheritance. Our patient meets the suggested criteria for the diagnosis of myoclonus dystonia as described above. SGCE testing in his father confirmed that his father also has a diagnosis of myoclonus dystonia, rather than the previous diagnosis of Tourette syndrome.

AUTHOR CONTRIBUTIONS

Dr. Blackburn qualifies as an author for drafting and revising the manuscript for content including medical writing for content. Dr. Cirillo qualifies as an author for drafting and revising the manuscript for content including medical writing for content.

Footnotes

  • Disclosure: The authors report no disclosures.

  • Copyright © 2012 by AAN Enterprises, Inc.

REFERENCES

  1. 1.↵
    1. Sanger TD,
    2. Chen D,
    3. Fehlings DL,
    4. et al
    . Definition and classification of hyperkinetic movements in childhood. Mov Disord 2010; 25: 1538– 1549.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Muller U
    . The monogenic primary dystonias. Brain 2009; 132: 2005– 2025.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Uc EY,
    2. Rodnitzky RL
    . Childhood dystonia. Semin Pediatr Neurol 2003; 10: 52– 61.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Albanese A,
    2. Barnes MP,
    3. Bhatia KP,
    4. et al
    . A systematic review on the diagnosis and treatment of primary (idiopathic) dystonia and dystonia plus syndromes: report of an EFNS/MDS-ES Task Force. Eur J Neurol 2006; 13: 433– 444.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Kinugawa K,
    2. Vidailhet M,
    3. Clot F,
    4. Apartis E,
    5. Grabli D,
    6. Roze E
    . Myoclonus-dystonia: an update. Mov Disord 2009; 24: 479– 489.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Leuzzi V,
    2. Carducci C,
    3. Cardona F,
    4. Artiola C,
    5. Antonozzi I
    . Autosomal dominant GTP-CH deficiency presenting as a dopa-responsive myoclonus-dystonia syndrome. Neurology 2002; 59: 1241– 1243.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Gerrits MC,
    2. Foncke EM,
    3. de Haan R,
    4. et al
    . Phenotype-genotype correlation in Dutch patients with myoclonus-dystonia. Neurology 2006; 66: 759– 761.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Luciano MS,
    2. Ozelius L,
    3. Sims K,
    4. Raymond D,
    5. Liu L,
    6. Saunders-Pullman R
    . Responsiveness to levodopa in epsilon-sarcoglycan deletions. Mov Disord 2009; 24: 425– 428.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Azoulay-Zyss J,
    2. Roze E,
    3. Welter ML,
    4. et al
    . Bilateral deep brain stimulation of the pallidum for myoclonus-dystonia due to epsilon-sarcoglycan mutations: a pilot study. Arch Neurol 2011; 68: 94– 98.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Gruber D,
    2. Kuhn AA,
    3. Schoenecker T,
    4. et al
    . Pallidal and thalamic deep brain stimulation in myoclonus-dystonia. Mov Disord 2010; 25: 1733– 1743.
    OpenUrlCrossRefPubMed
View Abstract

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • SECTION 1
    • SECTION 2
    • SECTION 3
    • SECTION 4
    • SECTION 5
    • DISCUSSION
    • AUTHOR CONTRIBUTIONS
    • Footnotes
    • REFERENCES
  • Info & Disclosures
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

  • All Pediatric
  • Dystonia
  • Myoclonus

Alert Me

  • Alert me when eletters are published
Neurology: 98 (21)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • Neurology: Education
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2022 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise